Evaluating Fracture Risk

Tenenhouse A Kreiger N Hanley D . Canadian Multicentre Osteoporosis Study (CaMos). Drug Dev Res 2000; 49: 201–5.

Jaglal SB Hawker G Cameron C The Ontario osteoporosis strategy: implementation of a population-based osteoporosis action plan in Canada. Osteoporosis Research, Monitoring and Evaluation Working Group A. Osteoporos Int 2010; 21 (6): 903–8.

Papaioannou A Morin S Cheung AM 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 2010; 182: 1864–73.

World Health Organization. Fracture risk assessment tool (FRAX). Available: www.shef.ac.uk/FRAX/tool.jsp (accessed March 30, 2011).

Siminoski K Leslie WD Frame H Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J 2005; 56: 178–88.

Kanis JA . New osteoporosis guidelines for Canada. CMAJ 2010; 182: 1829–30.

Lewiecki EM . Risk communication and shared decision making in the care of patients with osteoporosis. J Clin Densitom 2010; 13 (4): 335–45.

Osteoporosis Canada. Medical conditions that can contribute to secondary osteoporosis. Available: www.osteoporosis.ca/index.php/ci_id/6603/la_id/1.htm (accessed March 30, 2011).

Mazziotti G Canalis E Giustina A . Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med 2010; 123 (10): 877–84.